Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Nancy Kemeny

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Procedures

Chemicals & Drugs

Anatomy

Hepatic Artery

Activities & Behaviors

Drug Evaluation

Concepts & Ideas

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
32
Saltz, Leonard
30
Fong, Yuman
30
Kelsen, David
19
Gonen, Mithat
18
Jarnagin, William
16
Minsky, Bruce
16
Blumgart, Leslie
16
Cohen, Alfred
14
Sigurdson, Elin
13
D'Angelica, Michael
12
DeMatteo, Ronald
11
Bertino, Joseph
11
Schwartz, Gary
11
Schwartz, Lawrence
11
Paty, Philip

Sign-in to see all Coauthors

Publications

TOP 3
Tse Archie N; Wu Nian; Patel Dina; Haviland Dana; Kemeny Nancy
A phase I study of gemcitabine given via intrahepatic pump for primary or metastatic hepatic malignancies.
Jarnagin W R; Schwartz L H; Gultekin D H; Gönen M; Haviland D; Shia J; D'Angelica M; Fong Y; Dematteo R; Tse A; Blumgart L H; Kemeny N
Regional chemotherapy for unresectable primary liver cancer: results of a phase II clinical trial and assessment of DCE-MRI as a biomarker of survival.
Gallagher David J; Libby Daniel M; Kemeny Nancy
Elevated carcinoembryonic antigen and sarcoidosis masquerading as metastatic colon cancer.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Nancy Kemeny (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Tse Archie N; Wu Nian; Patel Dina; Haviland Dana; Kemeny Nancy
A phase I study of gemcitabine given via intrahepatic pump for primary or metastatic hepatic malignancies.
Cancer chemotherapy and pharmacology 2009;64(5):935-44.
2009: Jarnagin W R; Schwartz L H; Gultekin D H; Gönen M; Haviland D; Shia J; D'Angelica M; Fong Y; Dematteo R; Tse A; Blumgart L H; Kemeny N
Regional chemotherapy for unresectable primary liver cancer: results of a phase II clinical trial and assessment of DCE-MRI as a biomarker of survival.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2009;20(9):1589-95.
2009: Gallagher David J; Libby Daniel M; Kemeny Nancy
Elevated carcinoembryonic antigen and sarcoidosis masquerading as metastatic colon cancer.
Clinical colorectal cancer 2009;8(3):172-4.
2009: Kemeny N; Capanu M; D'Angelica M; Jarnagin W; Haviland D; Dematteo R; Fong Y
Phase I trial of adjuvant hepatic arterial infusion (HAI) with floxuridine (FUDR) and dexamethasone plus systemic oxaliplatin, 5-fluorouracil and leucovorin in patients with resected liver metastases from colorectal cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2009;20(7):1236-41.
2009: Gallagher David J; Zheng Junting; Capanu Marinela; Haviland Dana; Paty Philip; Dematteo Robert P; D'Angelica Michael; Fong Yuman; Jarnagin William R; Allen Peter J; Kemeny Nancy
Response to neoadjuvant chemotherapy does not predict overall survival for patients with synchronous colorectal hepatic metastases.
Annals of surgical oncology 2009;16(7):1844-51.
2009: Onaitis Mark W; Petersen Rebecca P; Haney John C; Saltz Leonard; Park Bernard; Flores Raja; Rizk Nabil; Bains Manjit S; Dycoco Joseph; D'Amico Thomas A; Harpole David H; Kemeny Nancy; Rusch Valerie W; Downey Robert
Prognostic factors for recurrence after pulmonary resection of colorectal cancer metastases.
The Annals of thoracic surgery 2009;87(6):1684-8.
2009: Fong Yuman; Kim Teresa; Bhargava Amit; Schwartz Larry; Brown Karen; Brody Lynn; Covey Anne; Karrasch Matthias; Getrajdman George; Mescheder Axel; Jarnagin William; Kemeny Nancy
A herpes oncolytic virus can be delivered via the vasculature to produce biologic changes in human colorectal cancer.
Molecular therapy : the journal of the American Society of Gene Therapy 2009;17(2):389-94.
2009: Gallagher David; Kemeny Nancy
Treatment of patients with colorectal cancer: emphasis on liver metastases.
Expert opinion on pharmacotherapy 2009;10(1):109-24.
2008: Dizon Don S; Schwartz Joanna; Kemeny Nancy
Regional chemotherapy: a focus on hepatic artery infusion for colorectal cancer liver metastases.
Surgical oncology clinics of North America 2008;17(4):759-71, viii.
2008: Power Derek G; Healey-Bird Brian R; Kemeny Nancy E
Regional chemotherapy for liver-limited metastatic colorectal cancer.
Clinical colorectal cancer 2008;7(4):247-59.
2008: Endo Itaru; Gonen Mithat; Yopp Adam C; Dalal Kimberly M; Zhou Qin; Klimstra David; D'Angelica Michael; DeMatteo Ronald P; Fong Yuman; Schwartz Lawrence; Kemeny Nancy; O'Reilly Eileen; Abou-Alfa Ghassan K; Shimada Hiroshi; Blumgart Leslie H; Jarnagin William R
Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection.
Annals of surgery 2008;248(1):84-96.
2008: Ito Hiromichi; Are Chandrakanth; Gonen Mithat; D'Angelica Michael; Dematteo Ronald P; Kemeny Nancy E; Fong Yuman; Blumgart Leslie H; Jarnagin William R
Effect of postoperative morbidity on long-term survival after hepatic resection for metastatic colorectal cancer.
Annals of surgery 2008;247(6):994-1002.
2008: Shmelkov Sergey V; Butler Jason M; Hooper Andrea T; Hormigo Adilia; Kushner Jared; Milde Till; St Clair Ryan; Baljevic Muhamed; White Ian; Jin David K; Chadburn Amy; Murphy Andrew J; Valenzuela David M; Gale Nicholas W; Thurston Gavin; Yancopoulos George D; D'Angelica Michael; Kemeny Nancy; Lyden David; Rafii Shahin
CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors.
The Journal of clinical investigation 2008;118(6):2111-20.
2008: White Rebekah R; Schwartz Lawrence H; Munoz Jose A; Raggio Greer; Jarnagin William R; Fong Yuman; D'Angelica Michael I; Kemeny Nancy E
Assessing the optimal duration of chemotherapy in patients with colorectal liver metastases.
Journal of surgical oncology 2008;97(7):601-4.
2008: Pozzo Carmelo; Barone Carlo; Kemeny Nancy E
Advances in neoadjuvant therapy for colorectal cancer with liver metastases.
Cancer treatment reviews 2008;34(4):293-301.
2008: Covey Anne M; Brown Karen T; Jarnagin William R; Brody Lynn A; Schwartz Lawrence; Tuorto Scott; Sofocleous Constantinos T; D'Angelica Michael; Getrajdman George I; DeMatteo Ronald; Kemeny Nancy E; Fong Yuman
Combined portal vein embolization and neoadjuvant chemotherapy as a treatment strategy for resectable hepatic colorectal metastases.
Annals of surgery 2008;247(3):451-5.
2008: Gallagher David J; Kemeny Nancy
Second-line management of metastatic colorectal cancer.
Clinical colorectal cancer 2008;7(1):25-32.
2007: Lassmann Silke; Tang Laura; Capanu Marinela; Brabletz Thomas; Schöpflin Anja; Zur Hausen Axel; Gonen Mithat; Kemeny Nancy; Shia Jinru; Klimstra David; Werner Martin
Predictive molecular markers for colorectal cancer patients with resected liver metastasis and adjuvant chemotherapy.
Gastroenterology 2007;133(6):1831-9.
2007: Scope Alon; Agero Anna Liza C; Dusza Stephen W; Myskowski Patricia L; Lieb Jocelyn A; Saltz Leonard; Kemeny Nancy E; Halpern Allan C
Randomized double-blind trial of prophylactic oral minocycline and topical tazarotene for cetuximab-associated acne-like eruption.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(34):5390-6.
2007: Gallagher D J; Capanu M; Raggio G; Kemeny N
Hepatic arterial infusion plus systemic irinotecan in patients with unresectable hepatic metastases from colorectal cancer previously treated with systemic oxaliplatin: a retrospective analysis.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(12):1995-9.
2007: Tomlinson James S; Jarnagin William R; DeMatteo Ronald P; Fong Yuman; Kornprat Peter; Gonen Mithat; Kemeny Nancy; Brennan Murray F; Blumgart Leslie H; D'Angelica Michael
Actual 10-year survival after resection of colorectal liver metastases defines cure.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(29):4575-80.
2007: Saltz Leonard B; Lenz Heinz-Josef; Kindler Hedy L; Hochster Howard S; Wadler Scott; Hoff Paulo M; Kemeny Nancy E; Hollywood Ellen M; Gonen Mithat; Quinones Marcus; Morse Meroe; Chen Helen X
Randomized phase II trial of cetuximab, bevacizumab, and irinotecan compared with cetuximab and bevacizumab alone in irinotecan-refractory colorectal cancer: the BOND-2 study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(29):4557-61.
2007: Miller George; Biernacki Peter; Kemeny Nancy E; Gonen Mithat; Downey Robert; Jarnagin William R; D'Angelica Michael; Fong Yuman; Blumgart Leslie H; DeMatteo Ronald P
Outcomes after resection of synchronous or metachronous hepatic and pulmonary colorectal metastases.
Journal of the American College of Surgeons 2007;205(2):231-8.
2007: Kemeny Nancy
Presurgical chemotherapy in patients being considered for liver resection.
The oncologist 2007;12(7):825-39.
2007: Parks Rowan; Gonen Mithat; Kemeny Nancy; Jarnagin William; D'Angelica Michael; DeMatteo Ronald; Garden O James; Blumgart Leslie H; Fong Yuman
Adjuvant chemotherapy improves survival after resection of hepatic colorectal metastases: analysis of data from two continents.
Journal of the American College of Surgeons 2007;204(5):753-61; discussion 761-3.
2007: D'Angelica Michael; Kornprat Peter; Gonen Mithat; Chung Ki-Young; Jarnagin William R; DeMatteo Ronald P; Fong Yuman; Kemeny Nancy; Blumgart Leslie H; Saltz Leonard B
Lack of evidence for increased operative morbidity after hepatectomy with perioperative use of bevacizumab: a matched case-control study.
Annals of surgical oncology 2007;14(2):759-65.
2006: Kemeny Nancy; Brown Karen; Covey Anne; Kim Teresa; Bhargava Amit; Brody Lynn; Guilfoyle Brenda; Haag Natasha P; Karrasch Matthias; Glasschroeder Birgit; Knoll Anette; Getrajdman George; Kowal K Jon; Jarnagin William R; Fong Yuman
Phase I, open-label, dose-escalating study of a genetically engineered herpes simplex virus, NV1020, in subjects with metastatic colorectal carcinoma to the liver.
Human gene therapy 2006;17(12):1214-24.
2006: Locker Gershon Y; Hamilton Stanley; Harris Jules; Jessup John M; Kemeny Nancy; Macdonald John S; Somerfield Mark R; Hayes Daniel F; Bast Robert C;
ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(33):5313-27.
2006: Kemeny Nancy
Management of liver metastases from colorectal cancer.
Oncology (Williston Park, N.Y.) 2006;20(10):1161-76, 1179; discussion 1179-80, 1185-6.
2006: Sofocleous Constantinos T; Schubert Johanna; Kemeny Nancy; Covey Anne M; Brody Lynn A; Getrajdman George I; Thornton Raymond; Winston Corinne; Brown Karen T
Arterial embolization for salvage of hepatic artery infusion pumps.
Journal of vascular and interventional radiology : JVIR 2006;17(5):801-6.
2006: Fury Matthew G; Krug Lee M; Azzoli Christopher G; Sharma Sunil; Kemeny Nancy; Wu Nian; Kris Mark G; Rizvi Naiyer A
A phase I clinical pharmacologic study of pralatrexate in combination with probenecid in adults with advanced solid tumors.
Cancer chemotherapy and pharmacology 2006;57(5):671-7.
2006: Kemeny Nancy E; Niedzwiecki Donna; Hollis Donna R; Lenz Heinz-Josef; Warren Robert S; Naughton Michelle J; Weeks Jane C; Sigurdson Elin R; Herndon James E; Zhang Chunfeng; Mayer Robert J
Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481).
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(9):1395-403.
2006: Leonard Gregory D; Kemeny Nancy E
Continued survival of more than ten years, without resection of metastatic disease, in patients with metastatic colorectal cancer treated with biomodulated fluorouracil: report of two cases.
Diseases of the colon and rectum 2006;49(3):407-10.
2005: Leonard Gregory D; Shia Jinru; Kemeny Nancy E
Metastases to the breast from primary pancreatic cancer.
The breast journal 2005;11(6):503.
2005: Chung Ki Young; Kemeny Nancy
Regional and systemic chemotherapy for primary hepatobiliary cancers and for colorectal cancer metastatic to the liver.
Seminars in radiation oncology 2005;15(4):284-98.
2005: Kelly Ronan J; Kemeny Nancy E; Leonard Gregory D
Current strategies using hepatic arterial infusion chemotherapy for the treatment of colorectal cancer.
Clinical colorectal cancer 2005;5(3):166-74.
2005: Kemeny Nancy; Eid Ahmed; Stockman Jennifer; Gonen Mithat; Schwartz Lawrence; Tetzlaff Eric; Paty Philip
Hepatic arterial infusion of floxuridine and dexamethasone plus high-dose Mitomycin C for patients with unresectable hepatic metastases from colorectal carcinoma.
Journal of surgical oncology 2005;91(2):97-101.
2005: Kemeny Nancy; Jarnagin William; Paty Philip; Gönen Mithat; Schwartz Lawrence; Morse Meroë; Leonard Gregory; D'Angelica Michael; DeMatteo Ronald; Blumgart Leslie; Fong Yuman
Phase I trial of systemic oxaliplatin combination chemotherapy with hepatic arterial infusion in patients with unresectable liver metastases from colorectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(22):4888-96.
2005: Allen Peter J; Nissan Aviram; Picon Antonio I; Kemeny Nancy; Dudrick Paul; Ben-Porat Leah; Espat Joseph; Stojadinovic Alexander; Cohen Alfred M; Fong Yuman; Paty Philip B
Technical complications and durability of hepatic artery infusion pumps for unresectable colorectal liver metastases: an institutional experience of 544 consecutive cases.
Journal of the American College of Surgeons 2005;201(1):57-65.
2005: Shah Manish A; Kemeny Nancy; Hummer Amanda; Drobnjak Marija; Motwani Monica; Cordon-Cardo Carlos; Gonen Mithat; Schwartz Gary K
Drg1 expression in 131 colorectal liver metastases: correlation with clinical variables and patient outcomes.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(9):3296-302.
2005: Leonard Gregory D; Brenner Baruch; Kemeny Nancy E
Neoadjuvant chemotherapy before liver resection for patients with unresectable liver metastases from colorectal carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(9):2038-48.
2005: Kortmansky Jeremy; Shah Manish A; Kaubisch Andreas; Weyerbacher Amanda; Yi Sandy; Tong William; Sowers Rebecca; Gonen Mithat; O'reilly Eileen; Kemeny Nancy; Ilson David I; Saltz Leonard B; Maki Robert G; Kelsen David P; Schwartz Gary K
Phase I trial of the cyclin-dependent kinase inhibitor and protein kinase C inhibitor 7-hydroxystaurosporine in combination with Fluorouracil in patients with advanced solid tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(9):1875-84.
2005: Chung Ki Young; Shia Jinru; Kemeny Nancy E; Shah Manish; Schwartz Gary K; Tse Archie; Hamilton Audrey; Pan Dorothy; Schrag Deborah; Schwartz Lawrence; Klimstra David S; Fridman Daniel; Kelsen David P; Saltz Leonard B
Cetuximab shows activity in colorectal cancer patients with tumors that do not express the epidermal growth factor receptor by immunohistochemistry.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(9):1803-10.
2005: Kemeny Nancy E; Gonen Mithat
Hepatic arterial infusion after liver resection.
The New England journal of medicine 2005;352(7):734-5.
2004: Kemeny Nancy; Garay Carlos A; Gurtler Jayne; Hochster Howard; Kennedy Peter; Benson Al; Brandt Debra Schwab; Polikoff Jonathan; Wertheim Michael; Shumaker Grace; Hallman Doreen; Burger Brent; Gupta Sunil
Randomized multicenter phase II trial of bolus plus infusional fluorouracil/leucovorin compared with fluorouracil/leucovorin plus oxaliplatin as third-line treatment of patients with advanced colorectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(23):4753-61.
2004: Leonard Gregory D; Sachs Dana; Kemeny Nancy E
Persistent CEA elevation in a patient with psoriasis and a history of metastatic colorectal cancer with no evidence of residual tumor.
Digestive diseases and sciences 2004;49(10):1652-3.
2004: Zalcberg J R; Kemeny Nancy E
Systemic or regional chemotherapy for liver metastases from colorectal cancer: has the wheel stopped spinning?
Cancer journal (Sudbury, Mass.) 2004;10(5):271-9.
2004: Carlo Waldemar F; Hummer Amanda J; Schwartz Lawrence; Sullivan Deidre; Gonen Mithat; Jarnagin William; Fong Yuman; Kemeny Nancy
Extent of hepatic resection does not correlate with toxicity following adjuvant chemotherapy.
Journal of surgical oncology 2004;87(2):85-90.
2004: Friedlander Philip A; Bansal Roopa; Schwartz Lawrence; Wagman Raquel; Posner Jerome; Kemeny Nancy
Gemcitabine-related radiation recall preferentially involves internal tissue and organs.
Cancer 2004;100(9):1793-9.
2004: Iwamoto Marian; Banerjee Debabrata; Menon Lata G; Jurkiewicz Anna; Rao Pulivarthi H; Kemeny Nancy E; Fong Yuman; Jhanwar Suresh C; Gorlick Richard; Bertino Joseph R
Overexpression of E2F-1 in lung and liver metastases of human colon cancer is associated with gene amplification.
Cancer biology & therapy 2004;3(4):395-9.
2004: Schwartz Gary K; Bertino Joseph; Kemeny Nancy; Saltz Leonard; Kelsen David K; Tong William; Welch Mary; Endres Sandra; Dimery Isaiah
Phase I trial of sequential raltitrexed followed by bolus 5-fluorouracil in patients with advanced colorectal cancer.
Anti-cancer drugs 2004;15(3):219-27.
2003: Kemeny N; Jarnagin W; Gonen M; Stockman J; Blumgart L; Sperber D; Hummer A; Fong Y
Phase I/II study of hepatic arterial therapy with floxuridine and dexamethasone in combination with intravenous irinotecan as adjuvant treatment after resection of hepatic metastases from colorectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(17):3303-9.
2003: Ramanathan Ramesh K; Clark Jeffery W; Kemeny Nancy E; Lenz Heinz-Josef; Gococo Kim O; Haller Daniel G; Mitchell Edith P; Kardinal Carl G
Safety and toxicity analysis of oxaliplatin combined with fluorouracil or as a single agent in patients with previously treated advanced colorectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(15):2904-11.
2003: Welt Sydney; Ritter Gerd; Williams Clarence; Cohen Leonard S; Jungbluth Achim; Richards Elizabeth A; Old Lloyd J; Kemeny Nancy E
Preliminary report of a phase I study of combination chemotherapy and humanized A33 antibody immunotherapy in patients with advanced colorectal cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(4):1347-53.
2003: Welt Sydney; Ritter Gerd; Williams Clarence; Cohen Leonard S; John Mary; Jungbluth Achim; Richards Elizabeth A; Old Lloyd J; Kemeny Nancy E
Phase I study of anticolon cancer humanized antibody A33.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(4):1338-46.
2003: Gonen Mithat; Hummer Amanda; Zervoudakis Alice; Sullivan Deidre; Fong Yuman; Banerjee Debabrata; Klimstra David; Cordon-Cardo Carlos; Bertino Joseph; Kemeny Nancy
Thymidylate synthase expression in hepatic tumors is a predictor of survival and progression in patients with resectable metastatic colorectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(3):406-12.
2003: Allen Peter J; Kemeny Nancy; Jarnagin William; DeMatteo Ronald; Blumgart Leslie; Fong Yuman
Importance of response to neoadjuvant chemotherapy in patients undergoing resection of synchronous colorectal liver metastases.
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 2003;7(1):109-15; discussion 116-7.
2003: Cohen Adam D; Kemeny Nancy E
An update on hepatic arterial infusion chemotherapy for colorectal cancer.
The oncologist 2003;8(6):553-66.
2002: Nash Garrett M; Saltz Leonard B; Kemeny Nancy E; Minsky Bruce; Sharma Sunil; Schwartz Gary K; Ilson David H; O'Reilly Eileen; Kelsen David P; Nathanson Daniel R; Weiser Martin; Guillem Jose G; Wong W Douglas; Cohen Alfred M; Paty Philip B
Radical resection of rectal cancer primary tumor provides effective local therapy in patients with stage IV disease.
Annals of surgical oncology 2002;9(10):954-60.
2002: Kemeny N; Tong W; Gonen M; Stockman J; Di Lauro C; Teitcher J; White P; Price C; Saltz L; Sharma S; Graham M A
Phase I study of weekly oxaliplatin plus irinotecan in previously treated patients with metastatic colorectal cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(9):1490-6.
2002: Sharma S; Kemeny N; Kelsen D P; Ilson D; O'Reilly E; Zaknoen S; Baum C; Statkevich P; Hollywood E; Zhu Y; Saltz L B
A phase II trial of farnesyl protein transferase inhibitor SCH 66336, given by twice-daily oral administration, in patients with metastatic colorectal cancer refractory to 5-fluorouracil and irinotecan.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(7):1067-71.
2002: Mayer-Kuckuk Philipp; Banerjee Debabrata; Kemeny Nancy; Fong Yuman; Bertino Joseph R
Molecular therapies for colorectal cancer metastatic to the liver.
Molecular therapy : the journal of the American Society of Gene Therapy 2002;5(5 Pt 1):492-500.
2002: Dizon Don S; Kemeny Nancy E
Intrahepatic arterial infusion of chemotherapy: clinical results.
Seminars in oncology 2002;29(2):126-35.
2002: Blanke C D; Shultz J; Cox J; Modiano M; Isaacs R; Kasimis B; Schilsky R; Fleagle J; Moore M; Kemeny N; Carlin D; Hammershaimb L; Haller D
A double-blind placebo-controlled randomized phase III trial of 5-fluorouracil and leucovorin, plus or minus trimetrexate, in previously untreated patients with advanced colorectal cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(1):87-91.
2001: Culliford A T; Brooks A D; Sharma S; Saltz L B; Schwartz G K; O'Reilly E M; Ilson D H; Kemeny N E; Kelsen D P; Guillem J G; Wong W D; Cohen A M; Paty P B
Surgical debulking and intraperitoneal chemotherapy for established peritoneal metastases from colon and appendix cancer.
Annals of surgical oncology 2001;8(10):787-95.
2001: Sharma S; Kemeny N; Schwartz G K; Kelsen D; O'Reilly E; Ilson D; Coyle J; De Jager R L; Ducharme M P; Kleban S; Hollywood E; Saltz L B
Phase I study of topoisomerase I inhibitor exatecan mesylate (DX-8951f) given as weekly 24-hour infusions three of every four weeks.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(12):3963-70.
2001: Kemeny N; Fata F
Hepatic-arterial chemotherapy.
The lancet oncology 2001;2(7):418-28.
2001: Kemeny N; Gonen M; Sullivan D; Schwartz L; Benedetti F; Saltz L; Stockman J; Fong Y; Jarnagin W; Bertino J; Tong W; Paty P
Phase I study of hepatic arterial infusion of floxuridine and dexamethasone with systemic irinotecan for unresectable hepatic metastases from colorectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(10):2687-95.
2001: Sanz-Altamira P M; O'Reilly E; Stuart K E; Raeburn L; Steger C; Kemeny N E; Saltz L B
A phase II trial of irinotecan (CPT-11) for unresectable biliary tree carcinoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(4):501-4.
2001: Bast R C; Ravdin P; Hayes D F; Bates S; Fritsche H; Jessup J M; Kemeny N; Locker G Y; Mennel R G; Somerfield M R;
2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(6):1865-78.
2001: O'Reilly E M; Stuart K E; Sanz-Altamira P M; Schwartz G K; Steger C M; Raeburn L; Kemeny N E; Kelsen D P; Saltz L B
A phase II study of irinotecan in patients with advanced hepatocellular carcinoma.
Cancer 2001;91(1):101-5.
2000: Kemeny N E
Hepatic arterial therapy for the treatment of metastatic colorectal cancer.
Seminars in oncology 2000;27(5 Suppl 10):126-31.
2000: Koea J B; Kemeny N
Hepatic artery infusion chemotherapy for metastatic colorectal carcinoma.
Seminars in surgical oncology 2000;19(2):125-34.
2000: Fata F; Ron I G; Maluf F; Klimstra D; Kemeny N
Intra-abdominal fibrosis after systemic and intraperitoneal therapy containing fluoropyrimidines.
Cancer 2000;88(11):2447-51.
2000: Banerjee D; Gorlick R; Liefshitz A; Danenberg K; Danenberg P C; Danenberg P V; Klimstra D; Jhanwar S; Cordon-Cardo C; Fong Y; Kemeny N; Bertino J R
Levels of E2F-1 expression are higher in lung metastasis of colon cancer as compared with hepatic metastasis and correlate with levels of thymidylate synthase.
Cancer research 2000;60(9):2365-7.
1999: Kemeny N E; Atiq O T
Non-surgical treatment for liver metastases.
Baillière's best practice & research. Clinical gastroenterology 1999;13(4):593-610.
1999: Kemeny N; Huang Y; Cohen A M; Shi W; Conti J A; Brennan M F; Bertino J R; Turnbull A D; Sullivan D; Stockman J; Blumgart L H; Fong Y
Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer.
The New England journal of medicine 1999;341(27):2039-48.
1999: Fong Y; Saldinger P F; Akhurst T; Macapinlac H; Yeung H; Finn R D; Cohen A; Kemeny N; Blumgart L H; Larson S M
Utility of 18F-FDG positron emission tomography scanning on selection of patients for resection of hepatic colorectal metastases.
American journal of surgery 1999;178(4):282-7.
1999: Kemeny N E; Ron I G
Hepatic arterial chemotherapy in metastatic colorectal patients.
Seminars in oncology 1999;26(5):524-35.
1999: Kemeny N E
Introduction: colorectal cancer: past accomplishments and future directions I.
Seminars in oncology 1999;26(5):475-7.
1999: Fata F; Ron I G; Kemeny N; O'Reilly E; Klimstra D; Kelsen D P
5-fluorouracil-induced small bowel toxicity in patients with colorectal carcinoma.
Cancer 1999;86(7):1129-34.
1999: Kronawitter U; Kemeny N E; Heelan R; Fata F; Fong Y
Evaluation of chest computed tomography in the staging of patients with potentially resectable liver metastases from colorectal carcinoma.
Cancer 1999;86(2):229-35.
1999: Kemeny N; Fata F
Arterial, portal, or systemic chemotherapy for patients with hepatic metastasis of colorectal carcinoma.
Journal of hepato-biliary-pancreatic surgery 1999;6(1):39-49.
1998: Saltz L B; Spriggs D; Schaaf L J; Schwartz G K; Ilson D; Kemeny N; Kanowitz J; Steger C; Eng M; Albanese P; Semple D; Hanover C K; Elfring G L; Miller L L; Kelsen D
Phase I clinical and pharmacologic study of weekly cisplatin combined with weekly irinotecan in patients with advanced solid tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(12):3858-65.
1998: Cohen A M; Garin-Chesa P; Hanson M; Weyhrauch K; Kemeny N; Fong Y; Paty P; Welt S; Old L
In vitro detection of occult bone marrow metastases in patients with colorectal cancer hepatic metastases.
Diseases of the colon and rectum 1998;41(9):1112-5.
1998: Sgouros G; O'Donoghue J A; Larson S M; Macapinlac H; Larson J J; Kemeny N
Mathematical model of 5-[125I]iodo-2'-deoxyuridine treatment: continuous infusion regimens for hepatic metastases.
International journal of radiation oncology, biology, physics 1998;41(5):1177-83.
1998: Gorlick R; Metzger R; Danenberg K D; Salonga D; Miles J S; Longo G S; Fu J; Banerjee D; Klimstra D; Jhanwar S; Danenberg P V; Kemeny N; Bertino J R
Higher levels of thymidylate synthase gene expression are observed in pulmonary as compared with hepatic metastases of colorectal adenocarcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(4):1465-9.
1998: Povoski S P; Fong Y; Sgouros S C; Kemeny N E; Downey R J; Blumgart L H
Role of chest CT in patients with negative chest x-rays referred for hepatic colorectal metastases.
Annals of surgical oncology 1998;5(1):9-15.
1998: Clark T B; Kemeny N E; Conti J A; Huang Y; Andre A M; Stockman J
Phase II trial of docetaxel (Taxotere) for untreated advanced colorectal carcinoma.
Cancer investigation 1998;16(5):314-8.
1997: Saltz L B; Kemeny N E; Tong W; Harrison J; Berkery R; Kelsen D P
9-Aminocamptothecin by 72-hour continuous intravenous infusion is inactive in the treatment of patients with 5-fluorouracil-refractory colorectal carcinoma.
Cancer 1997;80(9):1727-32.
1997: Kemeny N; Saltz L; Cohen A
Adjuvant therapy of colorectal cancer.
Surgical oncology clinics of North America 1997;6(4):699-722.
1997: Kronawitter U; Kemeny N E; Blumgart L
Neutropenic enterocolitis in a patient with colorectal carcinoma: unusual course after treatment with 5-fluorouracil and leucovorin--a case report.
Cancer 1997;80(4):656-60.
1997: Crystal R G; Hirschowitz E; Lieberman M; Daly J; Kazam E; Henschke C; Yankelevitz D; Kemeny N; Silverstein R; Ohwada A; Russi T; Mastrangeli A; Sanders A; Cooke J; Harvey B G
Phase I study of direct administration of a replication deficient adenovirus vector containing the E. coli cytosine deaminase gene to metastatic colon carcinoma of the liver in association with the oral administration of the pro-drug 5-fluorocytosine.
Human gene therapy 1997;8(8):985-1001.
1997: Grann A; Minsky B D; Cohen A M; Saltz L; Guillem J G; Paty P B; Kelsen D P; Kemeny N; Ilson D; Bass-Loeb J
Preliminary results of preoperative 5-fluorouracil, low-dose leucovorin, and concurrent radiation therapy for clinically resectable T3 rectal cancer.
Diseases of the colon and rectum 1997;40(5):515-22.
1997: Manne S L; Taylor K L; Dougherty J; Kemeny N
Supportive and negative responses in the partner relationship: their association with psychological adjustment among individuals with cancer.
Journal of behavioral medicine 1997;20(2):101-25.
1997: Brown K T; Kemeny N; Berger M F; Getrajdman G I; Napp T; Fong Y; Herman S; Kurtz R C; Botet J; Blumgart L H
Obstructive jaundice in patients receiving hepatic artery infusional chemotherapy: etiology, treatment implications, and complications after transhepatic biliary drainage.
Journal of vascular and interventional radiology : JVIR 1997;8(2):229-34.
1997: Minsky B D; Cohen A M; Enker W E; Saltz L; Guillem J G; Paty P B; Kelsen D P; Kemeny N; Ilson D; Bass J; Conti J
Preoperative 5-FU, low-dose leucovorin, and radiation therapy for locally advanced and unresectable rectal cancer.
International journal of radiation oncology, biology, physics 1997;37(2):289-95.
1996: Cohen A M; Kemeny N E; Köhne C H; Wils J; de Takats P G; Kerr D J
Is intra-arterial chemotherapy worthwhile in the treatment of patients with unresectable hepatic colorectal cancer metastases?
European journal of cancer (Oxford, England : 1990) 1996;32A(13):2195-205.
1996: Saltz L B; Kanowitz J; Kemeny N E; Schaaf L; Spriggs D; Staton B A; Berkery R; Steger C; Eng M; Dietz A; Locker P; Kelsen D P
Phase I clinical and pharmacokinetic study of irinotecan, fluorouracil, and leucovorin in patients with advanced solid tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(11):2959-67.
1996: Belluco C; Guillem J G; Kemeny N; Huang Y; Klimstra D; Berger M F; Cohen A M
p53 nuclear protein overexpression in colorectal cancer: a dominant predictor of survival in patients with advanced hepatic metastases.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(10):2696-701.
1996: Hayes D F; Bast R C; Desch C E; Fritsche H; Kemeny N E; Jessup J M; Locker G Y; Macdonald J S; Mennel R G; Norton L; Ravdin P; Taube S; Winn R J
Tumor marker utility grading system: a framework to evaluate clinical utility of tumor markers.
Journal of the National Cancer Institute 1996;88(20):1456-66.
1996: Kemeny N
Colorectal cancer--an undertreated disease.
Anti-cancer drugs 1996;7(6):623-9.
1996: Fong Y; Kemeny N; Paty P; Blumgart L H; Cohen A M
Treatment of colorectal cancer: hepatic metastasis.
Seminars in surgical oncology 1996;12(4):219-52.
1996: Welt S; Scott A M; Divgi C R; Kemeny N E; Finn R D; Daghighian F; Germain J S; Richards E C; Larson S M; Old L J
Phase I/II study of iodine 125-labeled monoclonal antibody A33 in patients with advanced colon cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(6):1787-97.
1996: Daghighian F; Humm J L; Macapinlac H A; Zhang J; Izzo J; Finn R; Kemeny N; Larson S M
Pharmacokinetics and dosimetry of iodine-125-IUdR in the treatment of colorectal cancer metastatic to liver.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1996;37(4 Suppl):29S-32S.
1996: Macapinlac H A; Kemeny N; Daghighian F; Finn R; Zhang J; Humm J; Squire O; Larson S M
Pilot clinical trial of 5-[125I]iodo-2'-deoxyuridine in the treatment of colorectal cancer metastatic to the liver.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1996;37(4 Suppl):25S-29S.
1996: Conti J A; Kemeny N E; Saltz L B; Huang Y; Tong W P; Chou T C; Sun M; Pulliam S; Gonzalez C
Irinotecan is an active agent in untreated patients with metastatic colorectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(3):709-15.
1995: Kemeny N E
Regional chemotherapy of colorectal cancer.
European journal of cancer (Oxford, England : 1990) 1995;31A(7-8):1271-6.
1995: Kemeny N
Chemotherapy for colorectal carcinoma: one small step forward, one step backward.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(6):1287-90.
1995: Divgi C R; Scott A M; Dantis L; Capitelli P; Siler K; Hilton S; Finn R D; Kemeny N; Kelsen D; Kostakoglu L
Phase I radioimmunotherapy trial with iodine-131-CC49 in metastatic colon carcinoma.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1995;36(4):586-92.
1995: Conti J A; Kemeny N E; Saltz L B; André A M; Grossano D D; Bertino J R
Continuous infusion fluorouracil/leucovorin and bolus mitomycin-C as a salvage regimen for patients with advanced colorectal cancer.
Cancer 1995;75(3):769-74.
1995: Minsky B D; Cohen A M; Enker W E; Kelsen D P; Kemeny N; Frankel J
Efficacy of postoperative 5-FU, high-dose leucovorin, and sequential radiation therapy for clinically resectable rectal cancer.
Cancer investigation 1995;13(1):1-7.
1994: Kemeny N; Conti J A; Cohen A; Campana P; Huang Y; Shi W J; Botet J; Pulliam S; Bertino J R
Phase II study of hepatic arterial floxuridine, leucovorin, and dexamethasone for unresectable liver metastases from colorectal carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(11):2288-95.
1994: Saltz L; Murphy B; Kemeny N; Bertino J; Tong W; Keefe D; Tzy-Jun Y; Tao Y; Kelsen D; O'Brien J P
A phase I trial of intrahepatic verapamil and doxorubicin. Regional therapy to overcome multidrug resistance.
Cancer 1994;74(10):2757-64.
1994: Kemeny N E; Conti J A; Bertino J R
Chemotherapy for colorectal cancer.
The New England journal of medicine 1994;331(10):680-1.
1994: Kemeny N
Current approaches to metastatic colorectal cancer.
Seminars in oncology 1994;21(4 Suppl 7):67-75.
1994: Welt S; Divgi C R; Kemeny N; Finn R D; Scott A M; Graham M; Germain J S; Richards E C; Larson S M; Oettgen H F
Phase I/II study of iodine 131-labeled monoclonal antibody A33 in patients with advanced colon cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(8):1561-71.
1994: Saltz L; Kemeny N; Schwartz G; Kelsen D
A phase II trial of alpha-interferon and 5-fluorouracil in patients with advanced carcinoid and islet cell tumors.
Cancer 1994;74(3):958-61.
1994: Bading J R; Sigurdson E R; Finn R D; Yeh S D; Ginos J; Kemeny N E; Larson S M
Transport limits cellular entry of hepatic arterially injected 5-[18F]fluoro-2'-deoxyuridine in human intrahepatic tumors.
Drug metabolism and disposition: the biological fate of chemicals 1994;22(4):643-50.
1994: Conti J A; Kemeny N; Klimstra D; Minsky B; Rusch V
Colon carcinoma metastatic to the trachea. Report of a case and a review of the literature.
American journal of clinical oncology 1994;17(3):227-9.
1994: Portenoy R K; Thaler H T; Kornblith A B; Lepore J M; Friedlander-Klar H; Coyle N; Smart-Curley T; Kemeny N; Norton L; Hoskins W
Symptom prevalence, characteristics and distress in a cancer population.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 1994;3(3):183-9.
1994: Conti J A; Kemeny N; Seiter K; Goker E; Tong W; André M; Ragusa K; Bertino J R
Trial of sequential trimetrexate, fluorouracil, and high-dose leucovorin in previously treated patients with gastrointestinal carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(4):695-700.
1994: Kemeny N; Seiter K; Conti J A; Cohen A; Bertino J R; Sigurdson E R; Botet J; Chapman D; Mazumdar M; Budd A J
Hepatic arterial floxuridine and leucovorin for unresectable liver metastases from colorectal carcinoma. New dose schedules and survival update.
Cancer 1994;73(4):1134-42.
1994: Minsky B; Cohen A; Enker W; Kelsen D; Kemeny N; Ilson D; Guillem J; Saltz L; Frankel J; Conti J
Preoperative 5-fluorouracil, low-dose leucovorin, and concurrent radiation therapy for rectal cancer.
Cancer 1994;73(2):273-80.
1994: Portenoy R K; Thaler H T; Kornblith A B; Lepore J M; Friedlander-Klar H; Kiyasu E; Sobel K; Coyle N; Kemeny N; Norton L
The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress.
European journal of cancer (Oxford, England : 1990) 1994;30A(9):1326-36.
1993: Minsky B D; Cohen A M; Kemeny N; Enker W E; Kelsen D P; Saltz L; Frankel J
The efficacy of preoperative 5-fluorouracil, high-dose leucovorin, and sequential radiation therapy for unresectable rectal cancer.
Cancer 1993;71(11):3486-92.
1993: Minsky B D; Cohen A M; Kemeny N; Enker W E; Kelsen D P; Schwartz G; Saltz L; Dougherty J; Frankel J; Wiseberg J
Pre-operative combined 5-FU, low dose leucovorin, and sequential radiation therapy for unresectable rectal cancer.
International journal of radiation oncology, biology, physics 1993;25(5):821-7.
1993: Seiter K; Kemeny N
Successful treatment of a desmoid tumor with doxorubicin.
Cancer 1993;71(7):2242-4.
1993: Seiter K; Kemeny N; Martin D; Schneider A; Williams L; Colofiore J; Sawyer R
Uridine allows dose escalation of 5-fluorouracil when given with N-phosphonacetyl-L-aspartate, methotrexate, and leucovorin.
Cancer 1993;71(5):1875-81.
1993: Kemeny N; Conti J A; Sigurdson E; Cohen A; Seiter K; Lincer R; Niedzwiecki D; Botet J; Chapman D; Costa P
A pilot study of hepatic artery floxuridine combined with systemic 5-fluorouracil and leucovorin. A potential adjuvant program after resection of colorectal hepatic metastases.
Cancer 1993;71(6):1964-71.
1993: Kemeny N; Cohen A; Seiter K; Conti J A; Sigurdson E R; Tao Y; Niedzwiecki D; Botet J; Budd A
Randomized trial of hepatic arterial floxuridine, mitomycin, and carmustine versus floxuridine alone in previously treated patients with liver metastases from colorectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(2):330-5.
1993: Kemeny N; Lokich J J; Anderson N; Ahlgren J D
Recent advances in the treatment of advanced colorectal cancer.
Cancer 1993;71(1):9-18.
1992: O'Boyle K P; Zamore R; Adluri S; Cohen A; Kemeny N; Welt S; Lloyd K O; Oettgen H F; Old L J; Livingston P O
Immunization of colorectal cancer patients with modified ovine submaxillary gland mucin and adjuvants induces IgM and IgG antibodies to sialylated Tn.
Cancer research 1992;52(20):5663-7.
1992: Minsky B D; Cohen A M; Kemeny N; Enker W E; Kelsen D P; Reichman B; Saltz L; Sigurdson E R; Frankel J
Combined modality therapy of rectal cancer: decreased acute toxicity with the preoperative approach.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(8):1218-24.
1992: Smith J W; Kemeny N; Caldwell C; Banner P; Sigurdson E; Huvos A
Pseudomyxoma peritonei of appendiceal origin. The Memorial Sloan-Kettering Cancer Center experience.
Cancer 1992;70(2):396-401.
1992: Kemeny N; Conti J A; Seiter K; Niedzwiecki D; Botet J; Martin D; Costa P; Wiseberg J; McCulloch W
Biochemical modulation of bolus fluorouracil by PALA in patients with advanced colorectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(5):747-52.
1992: Martin D S; Kemeny N E
Modulation of fluorouracil by N-(phosphonacetyl)-L-asparate: a review.
Seminars in oncology 1992;19(2 Suppl 3):49-55.
1992: Martin D S; Kemeny N E
Overview of N-(phosphonacetyl)-L-aspartate + fluorouracil in clinical trials.
Seminars in oncology 1992;19(2 Suppl 3):228-33.
1992: Kemeny N; Younes A
Alfa-2A interferon and 5-fluorouracil for advanced colorectal carcinoma: the Memorial Sloan-Kettering experience.
Seminars in oncology 1992;19(2 Suppl 3):171-5.
1992: Kemeny N
Review of regional therapy of liver metastases in colorectal cancer.
Seminars in oncology 1992;19(2 Suppl 3):155-62.
1992: Conti J A; Kemeny N
Type Ia glycogenosis associated with hepatocellular carcinoma.
Cancer 1992;69(6):1320-2.
1992: Atiq O T; Kemeny N; Niedzwiecki D; Botet J
Treatment of unresectable primary liver cancer with intrahepatic fluorodeoxyuridine and mitomycin C through an implantable pump.
Cancer 1992;69(4):920-4.
1992: Minsky B D; Cohen A M; Kemeny N; Enker W E; Kelsen D P; Reichman B; Saltz L; Sigurdson E R; Frankel J
Enhancement of radiation-induced downstaging of rectal cancer by fluorouracil and high-dose leucovorin chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(1):79-84.
1992: Kemeny N; Seiter K; Niedzwiecki D; Chapman D; Sigurdson E; Cohen A; Botet J; Oderman P; Murray P
A randomized trial of intrahepatic infusion of fluorodeoxyuridine with dexamethasone versus fluorodeoxyuridine alone in the treatment of metastatic colorectal cancer.
Cancer 1992;69(2):327-34.
1992: Minsky B D; Cohen A M; Enker W E; Kelsen D P; Kemeny N; Riechman B; Saltz L; Sigurdson E R; Frankel J
Phase I trial of postoperative 5-FU, radiation therapy, and high dose leucovorin for resectable rectal cancer.
International journal of radiation oncology, biology, physics 1992;22(1):139-45.
1992: Kemeny N E
Is hepatic infusion of chemotherapy effective treatment for liver metastases? Yes!
Important advances in oncology 1992;():207-27.
1991: Kemeny N; Seiter K; Martin D; Urmacher C; Niedzwiecki D; Kurtz R C; Costa P; Murray M
A new syndrome: ascites, hyperbilirubinemia, and hypoalbuminemia after biochemical modulation of fluorouracil with N-phosphonacetyl-L-aspartate (PALA)
Annals of internal medicine 1991;115(12):946-51.
1991: Minsky B D; Kemeny N; Armstrong J G; Reichman B; Botet J
Extrahepatic biliary system cancer: an update of a combined modality approach.
American journal of clinical oncology 1991;14(5):433-7.
1991: Crown J; Jakubowski A; Kemeny N; Gordon M; Gasparetto C; Wong G; Sheridan C; Toner G; Meisenberg B; Botet J
A phase I trial of recombinant human interleukin-1 beta alone and in combination with myelosuppressive doses of 5-fluorouracil in patients with gastrointestinal cancer.
Blood 1991;78(6):1420-7.
1991: Kemeny N; Seiter K
Therapy for colorectal cancer.
Current opinion in oncology 1991;3(4):745-52.
1991: Minsky B D; Cohen A M; Enker W E; Kelsen D; Kemeny N; Sigurdson E
Adjuvant postoperative radiation therapy for resectable rectal cancer.
Radiation medicine 1991;9(4):153-8.
1991: Minsky B D; Kemeny N; Cohen A M; Enker W E; Kelsen D P; Reichman B; Saltz L; Sigurdson E R; Frankel J
Preoperative high-dose leucovorin/5-fluorouracil and radiation therapy for unresectable rectal cancer.
Cancer 1991;67(11):2859-66.
1990: Kemeny N; Younes A; Seiter K; Kelsen D; Sammarco P; Adams L; Derby S; Murray P; Houston C
Interferon alpha-2a and 5-fluorouracil for advanced colorectal carcinoma. Assessment of activity and toxicity.
Cancer 1990;66(12):2470-5.
1990: Welt S; Divgi C R; Real F X; Yeh S D; Garin-Chesa P; Finstad C L; Sakamoto J; Cohen A; Sigurdson E R; Kemeny N
Quantitative analysis of antibody localization in human metastatic colon cancer: a phase I study of monoclonal antibody A33.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(11):1894-906.
1990: Kemeny N; Childs B; Larchian W; Rosado K; Kelsen D
A phase II trial of recombinant tumor necrosis factor in patients with advanced colorectal carcinoma.
Cancer 1990;66(4):659-63.
1990: Kemeny N; Cohen A; Bertino J R; Sigurdson E R; Botet J; Oderman P
Continuous intrahepatic infusion of floxuridine and leucovorin through an implantable pump for the treatment of hepatic metastases from colorectal carcinoma.
Cancer 1990;65(11):2446-50.
1990: Minsky B D; Wesson M F; Armstrong J G; Kemeny N; Reichman B; Botet J; Nori D
Combined modality therapy of extrahepatic biliary system cancer.
International journal of radiation oncology, biology, physics 1990;18(5):1157-63.
1990: Kemeny N; Israel K; Niedzwiecki D; Chapman D; Botet J; Minsky B; Vinciguerra V; Rosenbluth R; Bosselli B; Cochran C
Randomized study of continuous infusion fluorouracil versus fluorouracil plus cisplatin in patients with metastatic colorectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(2):313-8.
1990: Kemeny N; Israel K; O'Hehir M
Phase II trial of 10-Edam in patients with advanced colorectal carcinoma.
American journal of clinical oncology 1990;13(1):42-4.
1990: Kemeny N E; Schneider A; Martin D S
Phase I trial of PALA, methotrexate, fluorouracil, leucovorin, and uridine rescue in patients with advanced cancer. The use of uridine to decrease fluorouracil toxicity.
Cancer investigation 1990;8(2):263-4.
1989: O'Boyle K P; Kemeny N
Synchronous colon and renal cancers: six cases of a clinical entity.
The American journal of medicine 1989;87(6):691-3.
1989: Schneider A; Kemeny N; Chapman D; Niedzwiecki D; Oderman P
Intrahepatic mitomycin C as a salvage treatment for patients with hepatic metastases from colorectal carcinoma.
Cancer 1989;64(11):2203-6.
1989: Dougherty J B; Kelsen D; Kemeny N; Magill G; Botet J; Niedzwiecki D
Advanced pancreatic cancer: a phase I-II trial of cisplatin, high-dose cytarabine, and caffeine.
Journal of the National Cancer Institute 1989;81(22):1735-8.
1989: Kemeny N; Schneider A; Martin D S; Colofiore J; Sawyer R C; Derby S; Salvia B
Phase I trial of N-(phosphonacetyl)-L-aspartate, methotrexate, and 5-fluorouracil with leucovorin rescue in patients with advanced cancer.
Cancer research 1989;49(16):4636-9.
1989: Kemeny N; Schneider A
Regional treatment of hepatic metastases and hepatocellular carcinoma.
Current problems in cancer 1989;13(4):197-283.
1989: Kemeny N; Niedzwiecki D; Reichman B; Botet J; Vinciguerra V; Michaelson R; Rosenbluth R; Deonarine S
Cisplatin and 5-fluorouracil infusion for metastatic colorectal carcinoma. Differences in survival in two patient groups with similar response rates.
Cancer 1989;63(6):1065-9.
1989: Kemeny N; Niedzwiecki D; Shurgot B; Oderman P
Prognostic variables in patients with hepatic metastases from colorectal cancer. Importance of medical assessment of liver involvement.
Cancer 1989;63(4):742-7.
1989: Sugarbaker P H; Kemeny N
Management of metastatic cancer to the liver.
Advances in surgery 1989;22():1-56.
1988: Frame J; Kelsen D; Kemeny N; Cheng E; Niedzwiecki D; Heelan R; Lippermann R
A phase II trial of streptozotocin and adriamycin in advanced APUD tumors.
American journal of clinical oncology 1988;11(4):490-5.
1988: Jakubowski A A; Kemeny N
Hypotension as a manifestation of cardiotoxicity in three patients receiving cisplatin and 5-fluorouracil.
Cancer 1988;62(2):266-9.
1988: Kemeny N; Reichman B; Geller N; Hollander P
Implementation of the group sequential methodology in a randomized trial in metastatic colorectal carcinoma.
American journal of clinical oncology 1988;11(1):66-72.
1988: Reichman B; Markman M; Hakes T; Kemeny N; Kelsen D; Hoskins W; Rubin S; Lewis J L
Phase I trial of concurrent intraperitoneal and continuous intravenous infusion of fluorouracil in patients with refractory cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1988;6(1):158-62.
1987: Cohn K H; Welt S; Banner W P; Harrington M; Yeh S; Sakamoto J; Cardon-Cardo C; Daly J; Kemeny N; Cohen A
Localization of radioiodinated monoclonal antibody in colorectal cancer. Initial dosimetry results.
Archives of surgery (Chicago, Ill. : 1960) 1987;122(12):1425-9.
1987: Allen-Mersh T G; Kemeny N; Niedzwiecki D; Shurgot B; Daly J M
Significance of a fall in serum CEA concentration in patients treated with cytotoxic chemotherapy for disseminated colorectal cancer.
Gut 1987;28(12):1625-9.
1987: Sigurdson E R; Ridge J A; Kemeny N; Daly J M
Tumor and liver drug uptake following hepatic artery and portal vein infusion.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1987;5(11):1836-40.
1987: Daly J M; Kemeny N; Sigurdson E; Oderman P; Thom A
Regional infusion for colorectal hepatic metastases. A randomized trial comparing the hepatic artery with the portal vein.
Archives of surgery (Chicago, Ill. : 1960) 1987;122(11):1273-7.
1987: Kemeny N; Daly J; Reichman B; Geller N; Botet J; Oderman P
Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. A randomized trial.
Annals of internal medicine 1987;107(4):459-65.
1987: Kemeny N; Reichman B; Dougherty J; Lipperman R; Cheng E
Phase II trial of ifosfamide and mesna in advanced colorectal cancer.
Cancer treatment reports 1987;71(6):663-4.
1987: Reichman B S; Kemeny N E; Yeh S D
A complication of prolonged infusional chemotherapy masquerading as a bone metastasis in a patient with colorectal carcinoma.
Cancer 1987;59(6):1098-100.
1987: Fiore J J; Kemeny N E; Mehta B M; Geller N; Grossano D; Murphy D
Systemic absorption of a leucovorin mouth wash: a pharmacologic study.
Cancer investigation 1987;5(2):109-11.
1987: Kemeny N
Role of chemotherapy in the treatment of colorectal carcinoma.
Seminars in surgical oncology 1987;3(3):190-214.
1986: Fiore J; Kemeny N; Raymond V; Young C
Phase II trial of esorubicin in patients with advanced colorectal carcinoma.
Cancer treatment reports 1986;70(10):1241-2.
1986: Tauer K; Kemeny N; Cheng E; Hollander P; Geller N
Phase II trial of N-methylformamide in patients with advanced colorectal carcinoma.
Cancer treatment reports 1986;70(6):813-4.
1986: Shike M; Gillin J S; Kemeny N; Daly J M; Kurtz R C
Severe gastroduodenal ulcerations complicating hepatic artery infusion chemotherapy for metastatic colon cancer.
The American journal of gastroenterology 1986;81(3):176-9.
1986: Daly J M; Kemeny N
Therapy of colorectal hepatic metastases.
Important advances in oncology 1986;():251-68.
1986: Kemeny N; Daly J
Preliminary results of a randomized study of intrahepatic infusion versus systemic infusion of 5-fluoro-2'-deoxyuridine for metastatic colorectal carcinoma.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1986;100():171-8.
1985: Daly J M; Butler J; Kemeny N; Yeh S D; Ridge J A; Botet J; Bading J R; DeCosse J J; Benua R S
Predicting tumor response in patients with colorectal hepatic metastases.
Annals of surgery 1985;202(3):384-93.
1985: Botet J F; Watson R C; Kemeny N; Daly J M; Yeh S
Cholangitis complicating intraarterial chemotherapy in liver metastasis.
Radiology 1985;156(2):335-7.
1985: Lynch G; Kemeny N; Chun H; Martin D; Young C
Phase I evaluation and pharmacokinetic study of weekly iv thymidine and 5-FU in patients with advanced colorectal carcinoma.
Cancer treatment reports 1985;69(2):179-84.
1984: Daly J M; Kemeny N; Oderman P; Botet J
Long-term hepatic arterial infusion chemotherapy. Anatomic considerations, operative technique, and treatment morbidity.
Archives of surgery (Chicago, Ill. : 1960) 1984;119(8):936-41.
1984: Sternberg C N; Magill G B; Sordillo P P; Cheng E W; Kemeny N
Phase II evaluation of metoprine in advanced pancreatic adenocarcinoma.
Cancer treatment reports 1984;68(7-8):1053-4.
1984: Kemeny N; Daly J; Oderman P; Shike M; Chun H; Petroni G; Geller N
Hepatic artery pump infusion: toxicity and results in patients with metastatic colorectal carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1984;2(6):595-600.
1984: Harper H D; Kemeny N E; Ahmed T; Cheng E; Arena F; Sordillo P; Faye L
Phase II trial of 4-demethoxydaunorubicin in advanced colorectal carcinoma.
Cancer treatment reports 1984;68(4):689-90.
1984: Kemeny N E; Ahmed T; Michaelson R A; Harper H D; Yip L C
Activity of sequential low-dose methotrexate and fluorouracil in advanced colorectal carcinoma: attempt at correlation with tissue and blood levels of phosphoribosylpyrophosphate.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1984;2(4):311-5.
1984: Casper E S; Michaelson R A; Kemeny N; Martin D S; Young C W
Phase I evaluation of a biochemically designed combination: PALA, thymidine, and 5-FU.
Cancer treatment reports 1984;68(3):539-41.
1983: Kemeny N
The systemic chemotherapy of hepatic metastases.
Seminars in oncology 1983;10(2):148-58.
1983: Kemeny N; Braun D W
Prognostic factors in advanced colorectal carcinoma. Importance of lactic dehydrogenase level, performance status, and white blood cell count.
The American journal of medicine 1983;74(5):786-94.
1983: Chun H G; Yagoda A; Kemeny N; Watson R C
Cisplatin for adrenal cortical carcinoma.
Cancer treatment reports 1983;67(5):513-4.
1983: Ahmed T; Kemeny N E; Michaelson R A; Harper H D
Phase II trial of bisantrene in advanced colorectal carcinoma.
Cancer treatment reports 1983;67(3):307-8.
1983: Kemeny N; Yagoda A; Braun D
Metastatic colorectal carcinoma. A prospective randomized trial of Methyl-CCNU, 5-Fluorouracil (5-FU) and vincristine (MOF) versus MOF plus streptozotocin (MOF-Strep).
Cancer 1983;51(1):20-4.
1983: Cascino T L; Leavengood J M; Kemeny N; Posner J B
Brain metastases from colon cancer.
Journal of neuro-oncology 1983;1(3):203-9.
1982: Yonekura Y; Benua R S; Brill A B; Som P; Yeh S D; Kemeny N E; Fowler J S; MacGregor R R; Stamm R; Christman D R; Wolf A P
Increased accumulation of 2-deoxy-2-[18F]Fluoro-D-glucose in liver metastases from colon carcinoma.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1982;23(12):1133-7.
1982: Lynch G; Kemeny N; Casper E
Phase II evaluation of DON (6-diazo-5-oxo-L-norleucine) in patients with advanced colorectal carcinoma.
American journal of clinical oncology 1982;5(5):541-3.
1982: Michaelson R; Kemeny N; Young C
Phase II evaluation of 4'-epi-doxorubicin in patients with advanced colorectal carcinoma.
Cancer treatment reports 1982;66(9):1757-8.
1982: Wiley R G; Gralla R J; Casper E S; Kemeny N
Neurotoxicity of the pyrimidine synthesis inhibitor N-phosphonoacetyl-L-aspartate.
Annals of neurology 1982;12(2):175-83.
1981: Enker W E; Kemeny N; Shank B; Rotstein L
Defining the needs for adjuvant therapy of rectal and colonic cancer.
The Surgical clinics of North America 1981;61(6):1295-310.
1981: Kemeny N; Yagoda A; Wang Y; Field K; Wrobleski H; Whitmore W
Randomized trial of standard therapy with or without poly I:C in patients with superficial bladder cancer.
Cancer 1981;48(10):2154-7.
1981: Needles B; Kemeny N; Urmacher C
Malignant thymoma: renal metastases responding to cis-platinum.
Cancer 1981;48(2):223-6.
1981: Lynch G; Kemeny N; Currie V
Phase II evaluation of metoprine in patients with advanced colorectal carcinoma.
Cancer treatment reports 1981;65(1-2):127-8.
1981: Lynch G; Currie V; Kemeny N
Phase II evaluation of metoprine with leucovorin rescue in patients with advanced colorectal carcinoma.
Cancer clinical trials 1981;4(3):281-3.
1980: Carroll D S; Kemeny N; Lynch G; Wookcock T
Phase II evaluation of 4'-(9-acridinylamino)-methanesulfon-m-anisidide (AMSA) in patients with advanced colorectal carcinoma.
Cancer treatment reports 1980;64(10-11):1149-50.
1980: Woodcock T M; Martin D S; Damin L A; Kemeny N E; Young C W
Combination clinical trials with thymidine and fluorouracil: a phase I and clinical pharmacologic evaluation.
Cancer 1980;45(5 Suppl):1135-43.
1980: Kemeny N; Yagoda A; Braun D; Golbey R
Therapy for metastatic colorectal carcinoma with a combination of methyl-CCNU, 5-fluorouracil vincristine and streptozotocin (MOF-Strep).
Cancer 1980;45(5):876-81.
1980: Carroll D S; Gralla R J; Kemeny N E
Phase II evaluation of N-(phosphonacetyl-L-aspartic acid (PALA) in patients with advanced colorectal carcinoma.
Cancer treatment reports 1980;64(2-3):349-51.
1979: Carroll D S; Gralla R J; Kemeny N E
Phase II evaluation of vindesine in patients with advanced colorectal carcinoma.
Cancer treatment reports 1979;63(11-12):2097-8.
1979: Carroll D S; Kemeny N E; Gralla R J
Phase II evaluation of pyrazofurin in patients with advanced colorectal carcinoma.
Cancer treatment reports 1979;63(1):139-40.
1979: Kemeny N; Yagoda A; Braun D; Golbey R
A randomized study of two different schedules of methyl CCNU, 5-FU and vincristine for metastatic colorectal carcinoma.
Cancer 1979;43(1):78-82.
1978: Herr H W; Kemeny N; Yagoda A; Whitmore W F
Poly I:C immunotherapy in patients with papillomas or superficial carcinomas of the bladder.
National Cancer Institute monograph 1978;(49):325.
1978: Yagoda A; Watson R C; Kemeny N; Barzell W E; Grabstald H; Whitmore W F
Diamminedichloride platinum II and cyclophosphamide in the treatment of advanced urothelial cancer.
Cancer 1978;41(6):2121-30.
1978: Kemeny N; Yagoda A; Burchenal J H
Phase II study of 2,2'-anhydro-1-beta-D-arabinofuranosyl-5-fluorocytosine in advanced colorectal carcinoma.
Cancer treatment reports 1978;62(3):463-4.

Sign-in to see more